Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,480 | 171 | 99.4% |
| Education | $20.92 | 2 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $685.69 | 17 | $0 (2021) |
| Mylan Specialty L.P. | $417.36 | 26 | $0 (2024) |
| Novo Nordisk Inc | $388.30 | 23 | $0 (2024) |
| ABBVIE INC. | $305.11 | 14 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $162.91 | 10 | $0 (2021) |
| Daiichi Sankyo Inc. | $148.08 | 4 | $0 (2017) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $140.12 | 8 | $0 (2023) |
| Allergan, Inc. | $128.42 | 8 | $0 (2020) |
| PFIZER INC. | $124.83 | 8 | $0 (2024) |
| Exact Sciences Corporation | $120.86 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $416.93 | 19 | Mylan Specialty L.P. ($58.33) |
| 2023 | $355.98 | 17 | ABBVIE INC. ($72.40) |
| 2022 | $396.91 | 21 | ABBVIE INC. ($189.95) |
| 2021 | $212.69 | 14 | Mylan Specialty L.P. ($135.34) |
| 2020 | $303.02 | 15 | Janssen Pharmaceuticals, Inc ($96.45) |
| 2019 | $627.90 | 24 | Janssen Pharmaceuticals, Inc ($317.80) |
| 2018 | $377.17 | 24 | SANOFI-AVENTIS U.S. LLC ($90.98) |
| 2017 | $810.78 | 39 | Janssen Pharmaceuticals, Inc ($236.38) |
All Payment Transactions
173 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/04/2024 | Davol Inc. | Channel Drain (Device) | Food and Beverage | In-kind items and services | $43.49 | General |
| Category: Surgery | ||||||
| 10/30/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $26.46 | General |
| Category: NEUROSCIENCE | ||||||
| 10/23/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $16.51 | General |
| Category: Diabetes | ||||||
| 10/16/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $15.48 | General |
| Category: UROLOGY | ||||||
| 10/02/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $20.49 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 09/11/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $20.95 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 09/04/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $27.37 | General |
| Category: Oncology | ||||||
| 07/24/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), TRULANCE | Food and Beverage | In-kind items and services | $22.51 | General |
| Category: Gastroenterology | ||||||
| 07/24/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $22.23 | General |
| Category: Diabetes | ||||||
| 07/10/2024 | Currax Pharmaceuticals LLC | CONTRAVE (Drug) | Food and Beverage | In-kind items and services | $16.98 | General |
| Category: Obesity | ||||||
| 06/05/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $18.74 | General |
| Category: Respiratory | ||||||
| 05/22/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $16.16 | General |
| Category: Endocrinology | ||||||
| 05/08/2024 | USWM, LLC | Lucemyra (Drug) | Food and Beverage | In-kind items and services | $27.09 | General |
| Category: Psychiatry/Psychology | ||||||
| 05/01/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $18.47 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 04/18/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $21.75 | General |
| Category: Oncology | ||||||
| 04/02/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $16.30 | General |
| Category: NEUROSCIENCE | ||||||
| 03/21/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $21.75 | General |
| Category: ANTIBIOTIC | ||||||
| 03/06/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $25.29 | General |
| 01/17/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $18.91 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 12/14/2023 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $22.41 | General |
| Category: ANTIBIOTIC | ||||||
| 12/05/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $26.61 | General |
| Category: Oncology | ||||||
| 09/27/2023 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $17.18 | General |
| Category: NEUROSCIENCE | ||||||
| 08/24/2023 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $20.25 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 08/09/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $22.85 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/25/2023 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $19.33 | General |
| Category: Anticholinergics, Inhaled | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 136 | 413 | $66,550 | $36,792 |
| 2022 | 5 | 178 | 462 | $71,490 | $39,302 |
| 2021 | 5 | 230 | 561 | $78,520 | $47,238 |
| 2020 | 8 | 346 | 761 | $102,180 | $52,874 |
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 50 | 158 | $25,280 | $14,409 | 57.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 42 | 204 | $26,520 | $13,995 | 52.8% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 13 | 20 | $7,000 | $4,318 | 61.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 31 | 31 | $7,750 | $4,070 | 52.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 61 | 153 | $24,480 | $13,668 | 55.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 54 | 190 | $24,700 | $12,015 | 48.6% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 15 | 66 | $7,260 | $4,866 | 67.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 35 | 35 | $8,750 | $4,714 | 53.9% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 13 | 18 | $6,300 | $4,038 | 64.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 71 | 227 | $27,790 | $14,265 | 51.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 59 | 132 | $20,560 | $13,337 | 64.9% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 31 | 124 | $13,640 | $9,584 | 70.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 51 | 51 | $12,750 | $7,096 | 55.7% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 18 | 27 | $3,780 | $2,956 | 78.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 88 | 364 | $40,040 | $20,918 | 52.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 72 | 132 | $18,480 | $9,586 | 51.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 68 | 68 | $17,000 | $8,239 | 48.5% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 63 | 120 | $13,200 | $6,988 | 52.9% |
| 99496 | Transitional care management services, highly complexity, requiring face-to-face visits within 7 days of discharge | Office | 2020 | 17 | 22 | $6,600 | $4,496 | 68.1% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 13 | 13 | $1,820 | $1,090 | 59.9% |
| G0179 | Physician re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians to affirm the initial imp | Office | 2020 | 13 | 30 | $3,000 | $1,028 | 34.3% |
| G0180 | Physician certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians to affirm the initial implem | Office | 2020 | 12 | 12 | $2,040 | $529.08 | 25.9% |
About Dr. Jibran Khan, M.D
Dr. Jibran Khan, M.D is a Internal Medicine healthcare provider based in Woonsocket, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/06/2005. The National Provider Identifier (NPI) number assigned to this provider is 1902803935.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jibran Khan, M.D has received a total of $3,501 in payments from pharmaceutical and medical device companies, with $416.93 received in 2024. These payments were reported across 173 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($3,480).
As a Medicare-enrolled provider, Khan has provided services to 890 Medicare beneficiaries, totaling 2,197 services with total Medicare billing of $176,205. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Woonsocket, RI
- Active Since 07/06/2005
- Last Updated 04/01/2008
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1902803935
Products in Payments
- XARELTO (Drug) $585.32
- UBRELVY (Drug) $273.41
- Yupelri (Drug) $225.83
- Ozempic (Drug) $188.08
- Movantik (Drug) $148.08
- YUPELRI (Drug) $128.82
- Cologuard Collection Kit (Device) $120.86
- Victoza (Drug) $119.61
- INVOKANA (Drug) $100.37
- TOUJEO (Drug) $88.88
- STIOLTO RESPIMAT (Drug) $73.74
- SYMBICORT (Drug) $69.66
- XIFAXAN (Drug) $65.76
- Perforomist (Drug) $62.71
- CHANTIX (Drug) $62.39
- SOLIQUA (Drug) $60.28
- BYSTOLIC (Drug) $57.20
- ENTRESTO (Drug) $51.77
- Utibron (Drug) $46.18
- NUZYRA (Drug) $44.16
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Woonsocket
Dr. Ibrahim Elgabry, M.d, M.D
Internal Medicine — Payments: $147,921
Sapna Chowdhry, Md, MD
Internal Medicine — Payments: $113,627
Dr. Greigstone Yearwood, M.d, M.D
Internal Medicine — Payments: $8,093
Dr. Irfan Ahmad, M.d, M.D
Internal Medicine — Payments: $4,470
Deborah Rich, Md, MD
Internal Medicine — Payments: $3,372
Dr. Stanley Balon, M.d, M.D
Internal Medicine — Payments: $1,925